Literature DB >> 23284262

Current status of PET/CT in the diagnosis and follow up of lymphomas.

Carlos Alberto Buchpiguel1.   

Abstract

Lymphomas are a heterogeneous group of malignancies that have a distinct biological behavior according to the subtype and degree of differentiation. Adequate staging, which has a direct impact on prognosis, is essential to properly plan therapy. Structural cross-sectional imaging, such as computed tomography, has been the standard imaging tool to stage and monitor patients with lymphoma. However, molecular imaging such as positron emission tomography has shown complementary diagnostic and prognostic values. This review discusses the current value of positron emission tomography imaging using 2-[fluorine-18]fluoro-2-deoxy-d-glucose in staging, restaging, monitoring and detecting relapse in Hodgkin's and non-Hodgkin lymphoma.

Entities:  

Keywords:  Fluorodeoxyglucose F18/diagnostic use; Lymph Nodes/radionuclide imaging; Lymphoma, Hodgkin's disease; Lymphoma, non-Hodgkin; Lymphoma/radionuclide imaging; Positron-emission tomography

Year:  2011        PMID： 23284262      PMCID： PMC3520639          DOI： 10.5581/1516-8484.20110035

Source DB:  PubMed          Journal:  Rev Bras Hematol Hemoter        ISSN： 1516-8484


  48 in total

1.  18F-FDG PET after 2 cycles of ABVD predicts event-free survival in early and advanced Hodgkin lymphoma.

Authors:  Juliano J Cerci; Luís F Pracchia; Camila C G Linardi; Felipe A Pitella; Dominique Delbeke; Marisa Izaki; Evelinda Trindade; José Soares; Valeria Buccheri; José C Meneghetti
Journal:  J Nucl Med       Date:  2010-08-18       Impact factor: 10.057

2.  PET/CT in lymphoma: prospective study of enhanced full-dose PET/CT versus unenhanced low-dose PET/CT.

Authors:  Beatriz Rodríguez-Vigil; Nieves Gómez-León; Inmaculada Pinilla; Dolores Hernández-Maraver; Juan Coya; Luis Martín-Curto; Rosario Madero
Journal:  J Nucl Med       Date:  2006-10       Impact factor: 10.057

3.  Expert opinions on positron emission tomography and computed tomography imaging in lymphoma.

Authors:  Dominique Delbeke; Sigrid Stroobants; Eric de Kerviler; Christian Gisselbrecht; Michel Meignan; Peter S Conti
Journal:  Oncologist       Date:  2009

4.  (18)F-FDG PET/CT bone/bone marrow findings in Hodgkin's lymphoma may circumvent the use of bone marrow trephine biopsy at diagnosis staging.

Authors:  Gerard Moulin-Romsee; Elif Hindié; Xavier Cuenca; Pauline Brice; Didier Decaudin; Myriam Bénamor; Josette Brière; Marcela Anitei; Jean-Emmanuel Filmont; David Sibon; Eric de Kerviler; Jean-Luc Moretti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-04       Impact factor: 9.236

5.  Whole-body positron emission tomography using 18F-fluorodeoxyglucose for posttreatment evaluation in Hodgkin's disease and non-Hodgkin's lymphoma has higher diagnostic and prognostic value than classical computed tomography scan imaging.

Authors:  G Jerusalem; Y Beguin; M F Fassotte; F Najjar; P Paulus; P Rigo; G Fillet
Journal:  Blood       Date:  1999-07-15       Impact factor: 22.113

6.  Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography.

Authors:  Malik E Juweid; Gregory A Wiseman; Julie M Vose; Justine M Ritchie; Yusuf Menda; James E Wooldridge; Felix M Mottaghy; Eric M Rohren; Norbert M Blumstein; Alan Stolpen; Brian K Link; Sven N Reske; Michael M Graham; Bruce D Cheson
Journal:  J Clin Oncol       Date:  2005-04-18       Impact factor: 44.544

7.  Fused FDG-PET/contrast-enhanced CT detects occult subdiaphragmatic involvement of Hodgkin's lymphoma thereby identifying patients requiring six cycles of anthracycline-containing chemotherapy and consolidation radiation of spleen.

Authors:  M Picardi; A Soricelli; F Grimaldi; E Nicolai; A Gallamini; F Pane
Journal:  Ann Oncol       Date:  2010-08-06       Impact factor: 32.976

8.  Non-Hodgkin lymphoma and Hodgkin disease: coregistered FDG PET and CT at staging and restaging--do we need contrast-enhanced CT?

Authors:  Niklaus G Schaefer; Thomas F Hany; Christian Taverna; Burkhardt Seifert; Katrin D M Stumpe; Gustav K von Schulthess; Gerhard W Goerres
Journal:  Radiology       Date:  2004-07-23       Impact factor: 11.105

9.  Predictive value and diagnostic accuracy of F-18-fluoro-deoxy-glucose positron emission tomography treated grade 1 and 2 follicular lymphoma.

Authors:  Shrinivas Bishu; Joanna M Quigley; Shreenath R Bishu; Sarah M Olsasky; Richard A Stem; Valerie K Shostrom; Karen P Holdeman; Subash Paknikar; James O Armitage; Jordan H Hankins
Journal:  Leuk Lymphoma       Date:  2007-08

Review 10.  [18F-fluorodeoxyglucose positron emission tomography in the evaluation of therapy response assessment in lymphomas. Systematic literature review and meta-analysis].

Authors:  C Ramos-Font; A C Rebollo Aguirre; R Villegas Portero; A Romero Tabares; M Gallego Peinado; J M Llamas Elvira
Journal:  Rev Esp Med Nucl       Date:  2009 Mar-Apr
View more
  7 in total

1.  Correlation of texture feature analysis with bone marrow infiltration in initial staging of patients with lymphoma using 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography.

Authors:  Mahmoud A Kenawy; Magdy M Khalil; Mahmoud H Abdelgawad; H H El-Bahnasawy
Journal:  Pol J Radiol       Date:  2020-10-19

2.  Feasibility of a multimodal (18)F-FDG-directed lymph node surgical excisional biopsy approach for appropriate diagnostic tissue sampling in patients with suspected lymphoma.

Authors:  Stephen P Povoski; Nathan C Hall; Douglas A Murrey; Chadwick L Wright; Edward W Martin
Journal:  BMC Cancer       Date:  2015-05-08       Impact factor: 4.430

3.  (18)F-FDG PET/CT in Neurolymphomatosis: Report of 3 Cases.

Authors:  Nguyen Xuan Canh; Ngo Van Tan; Tran Thanh Tung; Nguyen Truong Son; Simone Maurea
Journal:  Asia Ocean J Nucl Med Biol       Date:  2014

4.  Metachronous presentation of small-cell rectal carcinoma on an 18F-FDG PET/CT follow-up for follicular lymphoma.

Authors:  Yousuf Qaseem; Joanna Fair; Sanaz Behnia; Saeed Elojeimy
Journal:  Radiol Case Rep       Date:  2017-06-07

5.  Multi-b value diffusion-weighted magnetic resonance imaging and intravoxel incoherent motion modeling: Differentiation of aggressive lymphoma lesions on initial treatment and activity assessment after chemotherapy.

Authors:  Cheng-Cheng Liao; Yun-Ying Qin; Qi Tang; Xiao-Hong Tan; Qing Ke; Yan Rong; Jian-Hong Zhong; Le-Qun Li; Hong Cen
Journal:  Medicine (Baltimore)       Date:  2019-02       Impact factor: 1.817

6.  Diffuse Large B-Cell Non-Hodgkin Lymphoma Involving Multiple Different Organs in a Young Adult with 18F-FDG PET/CT.

Authors:  Esra Arslan; Tamer Aksoy; Göksel Alçın; Nilay Ermantaş; Yasemin Özlük; Gülçin Yeğen; Tevfik Fikret Çermik
Journal:  Mol Imaging Radionucl Ther       Date:  2022-02-02

Review 7.  Case Report: Spontaneous Remission of an Infraorbital Follicular B-Cell Lymphoma: Case Report and Review of the Literature.

Authors:  Maxime Peeters; Joris Geusens; Fréderic Van der Cruyssen; Lucienne Michaux; Laurence de Leval; Thomas Tousseyn; Peter Vandenberghe; Constantinus Politis
Journal:  Pathol Oncol Res       Date:  2021-04-08       Impact factor: 3.201
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.